More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency Share Article Life sciences technology platform provider builds on demand for modern data pipelines, faster review and analytics and expands senior leadership "With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments to patients," said Raj Indupuri, Co-Founder and CEO of eClinical Solutions. MANSFIELD, Mass. (PRWEB) February 11, 2021 eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, today announced a more than 40-percent annual license growth of its elluminate® Clinical Data Platform in 2020. This brings the total global adoption of elluminate to over 100 life sciences companies. An end-to-end clinical data platform, elluminate is helping life sciences companies manage the increasing volume and diversity now available in clinical research including data streams from decentralized trials. By unifying diverse, disparate data sources into one centralized platform for real-time access, standardization and analysis, elluminate helps organizations maximize the value of their clinical data.